Yash J. Ashar, Devaki Mankad, Abhyuday Bhotika 
Dealstreet

Cyril Amarchand Mangaldas acts on Godrej Astec LifeSciences ₹238 crore rights issue

Godrej Astec LifeSciences is a prominent player in the agrochemical and pharmaceutical industries.

Bar & Bench

Cyril Amarchand Mangaldas has advised Astec LifeSciences, a subsidiary of Godrej Agrovet, on a ₹238.2 crore rights issue of equity shares.

The transaction team was led by Yash J. Ashar (Senior Partner) Devaki Mankad (Partner, Regional Co-Head - Capital Markets – West), and Abhyuday Bhotika (Partner), with support from Veena Raghav (Senior Associate Designate), Anna Kallivayalil (Associate) and Mahima Aggarwal (Associate).

Godrej Astec LifeSciences

Godrej Astec LifeSciences is a prominent player in the agrochemical and pharmaceutical industries. Their operations encompass the manufacturing and distribution of a wide array of agrochemical active ingredients and pharmaceutical intermediates. Key products include Triazole Fungicides, Herbicides, and Insecticides. The company boasts an impressive infrastructure with 9 manufacturing units and over 150 reactors

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

WhatsApp, Meta sued in US court for allegedly accessing users’ end-to-end encrypted messages

Karnataka High Court slams ED over “tentative instructions” in WinZO subsidiary’s plea for release of salaries

Delhi High Court upholds family pension to CRPF jawan's widow despite remarriage

Woman's right to inherited property can't be curbed by custom: Punjab & Haryana HC in 44-year case

Due diligence test in CPC not always a bar for amendment of pleadings after trial starts: Karnataka HC

SCROLL FOR NEXT